正文
何云博士在抗体药物研发领域有丰富的经验，目前在和铂医药的全资子公司诺纳生物负责创新大分子技术平台开发。曾任职于诺华大分子研发中心负责抗体工程和生物信息学；曾在金斯瑞负责搭建生物信息相关平台。在中科院生物物理研究所（
IBP
）获得博士学位，并在北京生命科学研究所（
NIBS
）进行博士后研究工作，其博士和博士后的相关研究主要是蛋白质结构预测和分子模拟。是多项国际专利的共同发明人。
Dr. Yun
He has extensive experience in antibody drug development. He is currently
leading the development of innovative technology platforms at Nona Biosciences,
a wholly-owned subsidiary of Harbour BioMed. Previously, he worked at Novartis,
where he was responsible for antibody engineering and bioinformatics, and at
GenScript, where he led the development of bioinformatics platforms.
Dr. Yun
He obtained his Ph.D. from the Institute of Biophysics, Chinese Academy of
Sciences (IBP), and conducted post-doctoral research at the National Institute
of Biological Sciences, Beijing (NIBS). His Ph.D. and post-doctoral research
focused primarily on protein structure prediction and molecular simulation. He
is a co-inventor of several international patents.
讲座题目：
诺纳生物的双特异性抗体技术平台
